The worldwide hyperphosphatemia industry is anticipated to reach a valuation of around USD 12.66 billion in 2023 and grow at a compound annual growth rate (CAGR) of more than 4.8% until 2033. By 2033, ...

Patient-reported outcomes ... conducted in partnership with the National Kidney Foundation (NKF) showed excessive number and large size of phosphate binder pills to be top barriers to consistent ...

The outcomes of patients on chronic renal ... hospitalizations and need for medications (e.g. phosphate binders and antihypertensives). [9] Daily dialysis is also reported to increase appetite ...

Aviceda Therapeutics has got biotech financing in 2025 off to a flying start by raising $207.5 million to take its lead drug for sight-robbing disease ... iron-based phosphate binder AP301 ...

PESHAWAR: Kidney patients on Thursday demonstrated to push the government for restoring free dialysis service for them. Shouting slogans outside the Peshawar Press Club, the protesters said the ...

Amidst Gaza's conflict, dialysis patients face dire circumstances due to destroyed facilities, shortages of supplies, and restricted access to treatment. Over 400 patients have died during the 18 ...

Health officials in the Gaza Strip say more than 400 dialysis patients have died during the 18-month Israel-Hamas war because of lack of proper treatment. Israel has restricted the supply of ...

But the toll is striking: Over 400 patients, representing around 40% of all dialysis cases in the territory, have died during the 18-month conflict because of lack of proper treatment, according ...

Mohamed Attiya, 54, right, and his son, Wasem, sit in front of their tent before heading to Shifa hospital for a dialysis session in Gaza City, Monday, April 14, 2025. (AP Photo/Jehad Alshrafi ...